Lei Wang

Background

About Lei Wang

My career has been shaped by a broad range of experiences across scientific, regulatory, clinical, CMC and business domains, offering me a comprehensive perspective on drug development. Starting as a physician, I gained a deep understanding of clinical practice and urgent patient needs, which inspired my transition into clinical research. As a scientist, I have designed and conducted cutting-edge research, building a robust scientific foundation and reinforcing my commitment to translating discoveries into clinical applications. My multi-faceted experience at Heidelberg University, TolerogenixX and MiGenTra GmbH has equipped me with the ability to navigate complex product development and regulatory pathways, translating scientific strategies into actionable clinical roadmaps that advance clinical trials and improve operational efficiency. My success in securing €12 million in Series A financing demonstrates my capacity to attract significant investment by aligning scientific achievements with business goals. My professional journey reflects a growth mindset, embracing challenges, and breaking barriers. Working in dynamic, cross-functional, and cross-organizational environments has not only helped me cultivate a servant leadership style but also strengthened my effective communication skills. I am eager to bring my T-shaped expertise, leadership acumen, and dedication to scientific excellence to advance innovative drug development and deliver transformative therapies to patients worldwide.